GPD2 | Glycerol-3-phosphate dehydrogenase 2 (mitochondrial) | Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
GPRC5A | G protein-coupled receptor, class C, group 5, member A | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GRHL1 | Grainyhead-like 1 (Drosophila) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HDAC2 | Histone deacetylase 2 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
HELZ | Helicase with zinc finger | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
HLA-DRA | Major histocompatibility complex, class II, DR alpha | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
HLA-E | Major histocompatibility complex, class I, E | Predicted membrane proteins
| | | | | Expressed in all |
HM13 | Histocompatibility (minor) 13 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
HTATIP2 | HIV-1 Tat interactive protein 2, 30kDa | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ICAM1 | Intercellular adhesion molecule 1 | Cancer-related genes Candidate cardiovascular disease genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ICAM3 | Intercellular adhesion molecule 3 | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
IER3IP1 | Immediate early response 3 interacting protein 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
IFITM1 | Interferon induced transmembrane protein 1 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
IGFLR1 | IGF-like family receptor 1 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ITGA3 | Integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | Cancer-related genes CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ITGA5 | Integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ITGA6 | Integrin, alpha 6 | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ITGAV | Integrin, alpha V | Cancer-related genes CD markers FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ITGAX | Integrin, alpha X (complement component 3 receptor 4 subunit) | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ITGB1 | Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ITGB5 | Integrin, beta 5 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ITM2B | Integral membrane protein 2B | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
ITPR3 | Inositol 1,4,5-trisphosphate receptor, type 3 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
JAM3 | Junctional adhesion molecule 3 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
JTB | Jumping translocation breakpoint | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
KDSR | 3-ketodihydrosphingosine reductase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
KIAA1715 | KIAA1715 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
KIDINS220 | Kinase D-interacting substrate, 220kDa | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KLK8 | Kallikrein-related peptidase 8 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
KRT5 | Keratin 5 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
KTN1 | Kinectin 1 (kinesin receptor) | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
LAG3 | Lymphocyte-activation gene 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LAMP1 | Lysosomal-associated membrane protein 1 | CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
LAMP2 | Lysosomal-associated membrane protein 2 | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
LAPTM4A | Lysosomal protein transmembrane 4 alpha | Predicted membrane proteins
| | | | | Expressed in all |
LAT | Linker for activation of T cells | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
LAT2 | Linker for activation of T cells family, member 2 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
LBR | Lamin B receptor | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
LCLAT1 | Lysocardiolipin acyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
LITAF | Lipopolysaccharide-induced TNF factor | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
LMAN1 | Lectin, mannose-binding, 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
LMO7 | LIM domain 7 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LRCH1 | Leucine-rich repeats and calponin homology (CH) domain containing 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
LRMP | Lymphoid-restricted membrane protein | Cytoskeleton related proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LSR | Lipolysis stimulated lipoprotein receptor | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
LY75 | Lymphocyte antigen 75 | CD markers Predicted membrane proteins
| | | | | Mixed |
M6PR | Mannose-6-phosphate receptor (cation dependent) | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
MAN1A2 | Mannosidase, alpha, class 1A, member 2 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |